High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli, +29

The Lancet

Hematological MalignancyNeuro-oncologyLymphoid NeoplasiaMedicinePrimary Cns Lymphoma +7

Increased interleukin-10 serum levels in patients with solid tumours

Claudio Fortis, Marco Foppoli, Luca Gianotti, +5

Cancer Letters

Cancer ImmunosurveillanceMedicineImmunologySolid TumoursPathology +3

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

Andrés J.M. Ferreri, Giovanni Donadoni, Maria Giuseppina Cabras, +15

Journal of Clinical Oncology

Risk‐tailored <scp>CNS</scp> prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

Andrés J.M. Ferreri, Marta Bruno‐Ventre, Giovanni Donadoni, +8

British Journal of Haematology

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

Andrés J.M. Ferreri, Stefania Dell’Oro, Marco Foppoli, +16

Neurology

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

Andrés J.M. Ferreri, Stefania Dell’Oro, Daniela Capello, +11

British Journal of Haematology

Gamma‐delta t‐cell lymphomas

Marco Foppoli, Andrés J.M. Ferreri

European Journal Of Haematology

Lymphoid NeoplasiaPcgdtl AccountsAutoimmune DiseaseGamma‐delta T‐cell LymphomasGamma-delta T-cell Lymphomas +12

<i>MYD88</i> L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study

Andrés J.M. Ferreri, Teresa Calimeri, Paolo Lopedote, +31

British Journal of Haematology

ImmunodeficienciesImmunologyPathologyReliable BiomarkersImmunotherapy +20

Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R‐IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high‐dose methotrexate‐based chemotherapy

Silvia Mappa, Emerenziana Marturano, Giada Licata, +14

Hematological Oncology

Stem Cell CollectionLymphoid NeoplasiaMedicineRefractory PcnslImmunology +13

Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure

Giulio Cavalli, Marco Foppoli, Luca Cabrini, +3

Frontiers in Immunology

Heart FailureImmunologyImmunotherapyInflammationIl-1 Receptor Antagonist +14